UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2003
OR
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from . . . . . . . . . . to . . . . . . . . . .
Commission file number 333-76473
EQUISTAR CHEMICALS, LP
(Exact name of registrant as specified in its charter)
| Delaware | 76-0550481 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| Incorporation or organization) | Identification No.) | |
| 1221 McKinney Street, | ||
| Suite 700, Houston, Texas | 77010 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrants telephone number, including area code: (713) 652-7200
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ü No
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes No ü
There is no established public trading market for the registrants equity securities.
PART I. FINANCIAL INFORMATION
EQUISTAR CHEMICALS, LP
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
| For the three months ended June 30, |
For the six months ended June 30, |
|||||||||||||||
| Millions of dollars |
2003 |
2002 |
2003 |
2002 |
||||||||||||
| Sales and other operating revenues: |
||||||||||||||||
| Trade |
$ | 1,217 | $ | 1,111 | $ | 2,444 | $ | 2,006 | ||||||||
| Related parties |
380 | 351 | 794 | 592 | ||||||||||||
| 1,597 | 1,462 | 3,238 | 2,598 | |||||||||||||
| Operating costs and expenses: |
||||||||||||||||
| Cost of sales |
1,517 | 1,390 | 3,193 | 2,552 | ||||||||||||
| Selling, general and administrative expenses |
44 | 41 | 84 | 81 | ||||||||||||
| Research and development expense |
10 | 9 | 19 | 18 | ||||||||||||
| Loss on sales of assets |
2 | | 14 | | ||||||||||||
| 1,573 | 1,440 | 3,310 | 2,651 | |||||||||||||
| Operating income (loss) |
24 | 22 | (72 | ) | (53 | ) | ||||||||||
| Interest expense |
(56 | ) | (51 | ) | (106 | ) | (103 | ) | ||||||||
| Interest income |
3 | 1 | 4 | 1 | ||||||||||||
| Other income (expense), net |
(20 | ) | | (21 | ) | 1 | ||||||||||
| Loss before cumulative effect of accounting change |
(49 | ) | (28 | ) | (195 | ) | (154 | ) | ||||||||
| Cumulative effect of accounting change |
| | | (1,053 | ) | |||||||||||
| Net loss and comprehensive loss |
$ | (49 | ) | $ | (28 | ) | $ | (195 | ) | $ | (1,207 | ) | ||||
See Notes to the Consolidated Financial Statements.
1
EQUISTAR CHEMICALS, LP
CONSOLIDATED BALANCE SHEETS
| Millions of dollars |
June 30, 2003 |
December 31, 2002 |
||||||
| ASSETS |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 143 | $ | 27 | ||||
| Accounts receivable: |
||||||||
| Trade, net |
445 | 490 | ||||||
| Related parties |
114 | 135 | ||||||
| Inventories |
478 | 424 | ||||||
| Prepaid expenses and other current assets |
36 | 50 | ||||||
| Total current assets |
1,216 | 1,126 | ||||||
| Property, plant and equipment, net |
3,405 | 3,565 | ||||||
| Investments |
65 | 65 | ||||||
| Other assets, net |
343 | 296 | ||||||
| Total assets |
$ | 5,029 | $ | 5,052 | ||||
| LIABILITIES AND PARTNERS CAPITAL |
||||||||
| Current liabilities: |
||||||||
| Accounts payable: |
||||||||
| Trade |
$ | 436 | $ | 421 | ||||
| Related parties |
46 | 38 | ||||||
| Current maturities of long-term debt |
31 | 32 | ||||||
| Accrued liabilities |
176 | 223 | ||||||
| Total current liabilities |
689 | 714 | ||||||
| Long-term debt |
2,223 | 2,196 | ||||||
| Other liabilities and deferred revenues |
391 | 221 | ||||||
| Commitments and contingencies |
||||||||
| Partners capital: |
||||||||
| Partners accounts |
1,763 | 1,958 | ||||||
| Accumulated other comprehensive loss |
(37 | ) | (37 | ) | ||||
| Total partners capital |
1,726 | 1,921 | ||||||
| Total liabilities and partners capital |
$ | 5,029 | $ | 5,052 | ||||
See Notes to the Consolidated Financial Statements.
2
EQUISTAR CHEMICALS, LP
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the six months ended |
||||||||
| Millions of dollars |
2003 |
2002 |
||||||
| Cash flows from operating activities: |
||||||||
| Net loss |
$ | (195 | ) | $ | (1,207 | ) | ||
| Adjustments to reconcile net loss to cash provided by (used in) operating activities: |
||||||||
| Cumulative effect of accounting change |
| 1,053 | ||||||
| Depreciation and amortization |
154 | 147 | ||||||
| Debt refinancing charge |
19 | | ||||||
| Loss on sales of assets |
14 | | ||||||
| Changes in assets and liabilities that provided (used) cash: |
||||||||
| Accounts receivable |
66 | (157 | ) | |||||
| Inventories |
(66 | ) | 3 | |||||
| Accounts payable |
23 | 68 | ||||||
| Other assets and liabilities, net |
84 | (46 | ) | |||||
| Cash provided by (used in) operating activities |
99 | (139 | ) | |||||
| Cash flows from investing activities: |
||||||||
| Proceeds from sales of assets |
54 | | ||||||
| Expenditures for property, plant and equipment |
(34 | ) | (29 | ) | ||||
| Contributions to affiliates |
| (6 | ) | |||||
| Cash provided by (used in) investing activities |
20 | (35 | ) | |||||
| Cash flows from financing activities: |
||||||||
| Issuance of long-term debt |
440 | | ||||||
| Repayment of long-term debt |
(440 | ) | (101 | ) | ||||
| Net borrowing under lines of credit |
| 100 | ||||||
| Other |
(3 | ) | (2 | ) | ||||
| Cash used in financing activities |
(3 | ) | (3 | ) | ||||
| Increase (decrease) in cash and cash equivalents |
116 | (177 | ) | |||||
| Cash and cash equivalents at beginning of period |
27 | 202 | ||||||
| Cash and cash equivalents at end of period |
$ | 143 | $ | 25 | ||||
See Notes to the Consolidated Financial Statements.
3
EQUISTAR CHEMICALS, LP
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. Basis of Preparation
The accompanying consolidated financial statements are unaudited and have been prepared from the books and records of Equistar Chemicals, LP (Equistar) in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X for interim financial information. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments, consisting only of normal, recurring adjustments, considered necessary for a fair presentation have been included. For further information, refer to the consolidated financial statements and notes thereto for the year ended December 31, 2002 included in the Equistar 2002 Annual Report on Form 10-K. Certain amounts from prior periods have been reclassified to conform to the current period presentation.
2. Company Ownership
Equistar is a Delaware limited partnership, which commenced operations on December 1, 1997. Prior to August 2002, Equistar was owned 41% by Lyondell Chemical Company (Lyondell), 29.5% by Millennium Chemicals Inc. (Millennium) and 29.5% by Occidental Petroleum Corporation (Occidental). On August 22, 2002, Lyondell completed the purchase of Occidentals interest in Equistar and, as a result, Lyondells ownership interest in Equistar increased to 70.5%.
3. Accounting Changes
In May 2003, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 150Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity. The statement establishes standards for classifying and measuring certain financial instruments with characteristics of both liabilities and equity and requires that certain financial instruments be classified as liabilities, or assets in some circumstances. SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003 and is otherwise effective for Equistar beginning in the third quarter 2003. Equistar does not expect SFAS No. 150 to have a material impact on its consolidated financial statements.
Equistar is implementing three accounting changes as discussed below.
Variable Interest EntitiesIn January 2003, the Financial Accounting Standards Board (FASB) issued Interpretation No. 46 (FIN 46), Consolidation of Variable Interest Entities. FIN 46 addresses certain situations in which a company should include in its financial statements the assets, liabilities and activities of another entity. FIN 46 applies immediately to entities created after January 31, 2003 and, for Equistar, applies to existing entities beginning in the third quarter 2003. The application of FIN 46 will result in the consolidation of an entity from which Equistar leases certain railcars. The consolidation of this entity as of June 30, 2003 would have resulted in a net increase in property, plant and equipment of $112 million, a decrease in prepaid expense of approximately $10 million and a $102 million increase in debt. The cumulative effect on income would not have been material.
Early Extinguishment of DebtIn April 2002, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. The primary impact of the statement on Equistar is the classification of gains or losses that result from the early extinguishment of debt as an element of income before extraordinary items. The Consolidated Statements of Income and Comprehensive Income reflect these changes for all periods presented.
Goodwill and Other Intangible AssetsEffective January 1, 2002, Equistar adopted SFAS No. 142, Goodwill and Other Intangible Assets. Upon implementation of SFAS No. 142, Equistar reviewed goodwill for impairment and concluded that the entire balance of goodwill was impaired, resulting in a $1.1 billion charge that was reported as the cumulative effect of the accounting change as of January 1, 2002.
4
EQUISTAR CHEMICALS, LP
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)(Continued)
4. Accounts Receivable
Under the terms of an October 2002 receivables sales agreement, Equistar agreed to sell, on an ongoing basis and without recourse, designated accounts receivable, up to a maximum of $100 million. The agreement is subject to Equistar maintaining its current debt rating by Standard & Poors rating service of the McGraw-Hill Companies and maintaining a rating no lower than one level below its current debt rating by Moodys Investors Service. At June 30, 2003 and December 31, 2002, the balances of Equistars accounts receivable sold under this arrangement were $100 million and $81 million, respectively.
5. Inventories
Inventories consisted of the following:
| Millions of dollars |
June 30, 2003 |
December 31, 2002 | ||||
| Finished goods |
$ | 274 | $ | 233 | ||
| Work-in-process |
14 | 12 | ||||
| Raw materials |
101 | 85 | ||||
| Materials and supplies |
89 | 94 | ||||
| Total inventories |
$ | 478 | $ | 424 | ||
6. Property, Plant and Equipment, Net
The components of property, plant and equipment, at cost, and the related accumulated depreciation were as follows:
| Millions of dollars |
June 30, 2003 |
December 31, 2002 | ||||
| Land |
$ | 76 | $ | 80 | ||
| Manufacturing facilities and equipment |
5,960 | 6,037 | ||||
| Construction in progress |
61 | 60 | ||||
| Total property, plant and equipment |
6,097 | 6,177 | ||||
| Less accumulated depreciation |
2,692 | 2,612 | ||||
| Property, plant and equipment, net |
$ | 3,405 | $ | 3,565 | ||
Depreciation and amortization of asset costs is summarized as follows:
| For the three months ended |
For the six months ended | |||||||||